Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An NIH funding note '2018 ( U.S. NIH Grant/Contract )' was added and a new page revision tag 'Revision: v3.6.6' was introduced, while the 'Plain Language Summary' and the previous revision tag 'Revision: v3.6.5' were removed.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:08.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new build of the site.
    Difference
    0.0%
    Check dated 2026-08-08T18:21:06.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, signaling a small page-level update. This change does not alter trial details or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-25T10:30:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's template or metadata. This appears to be an internal version bump rather than a change to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:38.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2. This reflects a minor update to the page content rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-26T23:09:56.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now indicates enrollment is closed for this study, and new sections titled How to Read a Study Record, Common Questions, and How to Join a Study have been added; the Intervention/Treatment header formatting was adjusted and the revision version updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:04:56.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.